Saitama, Japan

Kazuharu Tamazawa


Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Shiraoka, JA (1977)
  • Shiraokamachi, JP (1980)
  • Saitama, JP (1994 - 1997)

Company Filing History:


Years Active: 1977-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kazuharu Tamazawa: Innovator in Pharmaceutical Chemistry

Introduction

Kazuharu Tamazawa is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on dihydropyridine derivatives. With a total of 6 patents to his name, Tamazawa continues to push the boundaries of medicinal chemistry.

Latest Patents

Tamazawa's latest patents focus on the production of dihydropyridine-3,5-dicarboxylic acid ester derivatives. One of his notable processes involves producing diastereoisomer A or a pharmaceutically acceptable acid addition salt of 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(1-benzylpyrrolidin-3-yl) ester 5-methyl ester. This process includes subjecting a mixture of diastereoisomers A and B to column chromatography using silica gel as a carrier and a mixture of ethyl acetate and acetic acid as an eluant. The separation of the acetate of diastereoisomer A from the eluate is a key step in this innovative method.

Career Highlights

Kazuharu Tamazawa is currently employed at Yamanouchi Pharmaceutical Company Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the understanding and application of dihydropyridine compounds in medicine.

Collaborations

Tamazawa has collaborated with esteemed colleagues such as Toichi Takenaka and Tadao Kojima. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Kazuharu Tamazawa is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborative efforts continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…